Cereno presents promising preclinical CS585 data as accepted at EHA 2022 congress
12 Jun 2022Event
Promising preclinical CS585 data as accepted at EHA 2022 congress
Dr. Michael Holinstat, Ass. Prof. at University of Michigan Medical School; and Director Translation Research, Cereno, presents the abstract 'A First-In-Class Compound Targeting the IP Receptor for Prevention of Thrombosis Without Increased Risk of Bleeding' accepted at the EHA congress, held in June 9-12, 2022.